These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22128247)

  • 1. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.
    Chen CW; Yeh MK; Shiau CY; Chiang CH; Lu DW
    Int J Nanomedicine; 2013; 8():2613-27. PubMed ID: 23901275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer.
    Ding J; Feng M; Wang F; Wang H; Guan W
    Oncol Rep; 2015 Oct; 34(4):1825-34. PubMed ID: 26238930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.
    Chen Z; Deng J; Zhao Y; Tao T
    Int J Nanomedicine; 2012; 7():3803-11. PubMed ID: 22888235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
    Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
    J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors.
    Song F; Sakurai N; Okamoto A; Koide H; Oku N; Dewa T; Asai T
    Biol Pharm Bull; 2019; 42(6):996-1003. PubMed ID: 31155597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
    Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
    Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model.
    Liu HA; Liu YL; Ma ZZ; Wang JC; Zhang Q
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4789-94. PubMed ID: 21519028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined integrin α
    Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
    J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs.
    Harvie P; Dutzar B; Galbraith T; Cudmore S; O'Mahony D; Anklesaria P; Paul R
    J Liposome Res; 2003 Nov; 13(3-4):231-47. PubMed ID: 14670229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.